It increased, as 50 investors sold WOOF shares while 100 reduced holdings. About 965,870 shares traded. Valley Natl Bancorp now has $2.91B valuation. It closed at $11.03 lastly. Procter & Gamble Co (NYSE:PG) has risen 7.54% since November 12, 2016 and is uptrending. It has outperformed by 8.14% the S&P500. Days to cover decreased from 4.0 to 1.0 and the short interest percentage is 0.04% as of October 13. ATRS's SI was 3.40M shares in November as released by FINRA. Its down 51.21% from 6.97M shares previously. Antares Pharma (ATRS)'s Williams %R presently stands at -60.61. Moreover, Thompson Davis & has 1% invested in Antares Pharma Inc (NASDAQ:ATRS) for 192,734 shares. It has outperformed by 190.44% the S&P500. Us Retail Bank De reported 6.02 million shares stake. Its up 0.28, from 0.62 in 2017Q1. It improved, as 18 investors sold VLY shares while 61 reduced holdings. Rhumbline Advisers reported 146,925 shares or 0% of all its holdings. The stock increased 0.43% or $0.38 on November 10, reaching $88.16. Janney Montgomery Scott Ltd reported 0.01% of its portfolio in Valley National Bancorp (NYSE:VLY). Barclays Public Ltd Company has invested 0% in Valley National Bancorp (NYSE:VLY). Breton Hill Capital Ltd reported 0.08% of its portfolio in Valley National Bancorp (NYSE:VLY). Oregon Employees Retirement Fund holds 94,312 shares. The Pennsylvania-based Susquehanna Int Gru Llp has invested 0% in Valley National Bancorp (NYSE:VLY). 256,943 are held by Credit Suisse Ag. Sumitomo Mitsui Asset Mngmt invested in 0.01% or 5,573 shares. Wells Fargo & Company/mn controls 49,166 shares worth $159,000. Texas Permanent School Fund holds 59,334 shares or 0.07% of its portfolio. Thompson Davis & Co bought 124,348 shares as the company's stock 0.00%. One investment analyst has rated the stock with a sell rating, three have issued a buy rating and two have issued a strong buy rating to the company's stock. Therefore 46% are positive. The firm has "Hold" rating by SunTrust given on Thursday, October 5. On October 13, 2017 HC Wainwright updated its forecast on ATRS and giving a rating of "Buy" and a price target of $5.00. The company was maintained on Monday, May 29 by Keefe Bruyette & Woods.
Antares Pharma, Inc. (Antares), launched on April 29, 2005, is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The company has market cap of $287.79 million. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. It now has negative earnings. The Company makes a reusable, needle-free spring action injection device, ZOMA-Jet or Twin-Jector, which is marketed through its partners for use with human growth hormone (hGH).
Investors sentiment decreased to 2.07 in Q2 2017. Its down 0.80, from 2.87 in 2017Q1. Finally, ValuEngine lowered Antares Pharma from a "hold" rating to a "sell" rating in a report on Monday, October 16th. 36 funds opened positions while 26 raised stakes.
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Antares Pharma, Inc. Cv Starr Company Tru reported 80,000 shares.
Antares Pharma (NASDAQ:ATRS) last posted its quarterly earnings data on Tuesday, November 7th.
Antares Pharma (NASDAQ:ATRS) traded up $0.05 during mid-day trading on Monday, hitting $1.84.
ATRS has been the topic of several research reports. The California-based California State Teachers Retirement Systems has invested 0% in Antares Pharma Inc (NASDAQ:ATRS). Vanguard Grp Inc Incorporated has invested 0% in Antares Pharma Inc (NASDAQ:ATRS). Metropolitan Life Insur Communications Ny accumulated 103,987 shares or 0% of the stock.
The company is now up from yesterday's close of 1.79. MML Investors Services LLC grew its holdings in shares of Antares Pharma by 228.2% during the second quarter. Btim Corporation owns 0.7% invested in Procter & Gamble Co (NYSE:PG) for 497,321 shares.
Short traders are feeling a little more bearish on shares of the company lately if you consider the change in short interest. American International Group Inc now holds 96,335 shares valued at $312,000.
Since June 9, 2017, it had 1 buying transaction, and 0 insider sales for $363,272 activity.
Antares Pharma (ATRS) opened at $1.84 on Friday. Armistice Capital Llc sold 3.00 million shares as Antares Pharma Inc (ATRS)'s stock 0.00%. The Money Flow Index creates a ratio of Positive Money Flow and Negative Money Flow over time and scales it to a number between 0 and 100. VCA Antech had 12 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has "Buy" rating by H.C. Wainwright given on Friday, June 23. The company was maintained on Wednesday, November 8 by H.C. Wainwright. The firm has "Buy" rating given on Wednesday, March 9 by Jefferies. The rating was maintained by Jefferies on Monday, August 7 with "Buy". The rating was downgraded by Benchmark on Friday, February 10 to "Hold". Piper Jaffray Companies set a $4.00 target price on shares of Antares Pharma and gave the stock a "buy" rating in a research report on Wednesday, July 26th. UBS maintained it with "Neutral" rating and $81 target in Monday, October 26 report.